Mark Kawakami serves as Executive at Arcadia Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Mark Kawakami has executed 1 insider transactions totaling $1.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 1, 2024 involved purchasing 700 shares valued at $1.4K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 1, 2024 | RKDA | $1.4K | Purchase | 700 | $2.06 | Discretionary |
Mark Kawakami currently holds 1,981 shares of Arcadia Biosciences, Inc. (RKDA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Kawakami has been a net buyer of RKDA stock. They have purchased $1.4K and sold $0 worth of shares.
Mark Kawakami's most recent insider trade was on Aug 1, 2024, when they purchased 700 shares at $2.06 per share.
Get notified when new Form 4 filings are submitted